NCT04023253

Pharmacologic Effect for Female Overactive Bladder Syndrome: Mirabegron Versus Solifenacin

Comparisons of the Impact of Beta-3 Agonist Versus Antimuscarinics on Psychological Distress, Sexual Function, Bladder Wall Thickness and Blood Flow in Women With Overactive Bladder Syndrome: a Randomized Controlled Study.

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 120 (estimated)
• Sponsor: Far Eastern Memorial Hospital · Academic / Other
• Sex: Female
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

To assess the impact of mirabegron versus solifenacin on psychological distress, sexual function, bladder wall thickness and bladder blood flow.

Detailed description

To assess the impact of mirabegron versus solifenacin on psychological distress, sexual function, bladder wall thickness and blood flow.

Conditions

• Overactive Bladder Syndrome

Interventions

Type	Name	Description
DRUG	Mirabegron	Mirabegron 25 mg
DRUG	Solifenacin	Solifenacin 5 mg

Timeline

• Start date: 2019-08-01
• Primary completion: 2024-12-31
• Completion: 2024-12-31
• First posted: 2019-07-17
• Last updated: 2023-09-15

Locations

1 site across 1 country: Taiwan